EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 340 filers reported holding EXELIXIS INC in Q2 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $589,207 | +6.3% | 26,966 | -7.0% | 0.02% | +28.6% |
Q2 2023 | $554,343 | -3.2% | 29,008 | -1.7% | 0.01% | -6.7% |
Q1 2023 | $572,886 | +20.5% | 29,515 | -0.4% | 0.02% | +15.4% |
Q4 2022 | $475,442 | +3.1% | 29,641 | +0.9% | 0.01% | -7.1% |
Q3 2022 | $461,000 | -24.3% | 29,388 | +0.5% | 0.01% | -6.7% |
Q2 2022 | $609,000 | -5.4% | 29,240 | +3.0% | 0.02% | +15.4% |
Q1 2022 | $644,000 | +24.8% | 28,389 | +0.5% | 0.01% | +30.0% |
Q4 2021 | $516,000 | -13.6% | 28,254 | 0.0% | 0.01% | -16.7% |
Q3 2021 | $597,000 | +13.7% | 28,254 | -1.9% | 0.01% | +9.1% |
Q2 2021 | $525,000 | -20.9% | 28,801 | -2.1% | 0.01% | -21.4% |
Q1 2021 | $664,000 | +12.5% | 29,409 | 0.0% | 0.01% | +7.7% |
Q4 2020 | $590,000 | -19.6% | 29,409 | -2.0% | 0.01% | -27.8% |
Q3 2020 | $734,000 | -0.4% | 30,008 | -3.4% | 0.02% | -5.3% |
Q2 2020 | $737,000 | +37.2% | 31,058 | -0.4% | 0.02% | +26.7% |
Q1 2020 | $537,000 | -2.4% | 31,193 | 0.0% | 0.02% | +25.0% |
Q4 2019 | $550,000 | -8.5% | 31,193 | -8.3% | 0.01% | -14.3% |
Q3 2019 | $601,000 | -22.5% | 33,998 | -6.2% | 0.01% | -22.2% |
Q2 2019 | $775,000 | -10.8% | 36,243 | -0.7% | 0.02% | -14.3% |
Q1 2019 | $869,000 | +21.0% | 36,495 | 0.0% | 0.02% | +10.5% |
Q4 2018 | $718,000 | +11.0% | 36,495 | 0.0% | 0.02% | +26.7% |
Q3 2018 | $647,000 | +19.8% | 36,495 | +45.5% | 0.02% | +15.4% |
Q2 2018 | $540,000 | – | 25,090 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,966,038 | $282,918,000 | 60.81% |
NEXTHERA CAPITAL LP | 1,735,030 | $30,745,000 | 5.89% |
GREAT POINT PARTNERS LLC | 2,075,000 | $36,769,000 | 5.73% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 704,534 | $9,574,000 | 4.55% |
Matrix Capital Management Company, LP | 10,000,000 | $177,200,000 | 4.38% |
Consonance Capital Management LP | 3,879,050 | $68,737,000 | 3.70% |
Rhenman & Partners Asset Management AB | 1,261,414 | $22,352,000 | 2.24% |
BB BIOTECH AG | 2,785,000 | $49,350,000 | 1.31% |
CAPITAL MANAGEMENT CORP /VA | 285,575 | $5,060,000 | 1.29% |
TEALWOOD ASSET MANAGEMENT INC | 155,376 | $2,753,000 | 1.03% |